Delivery Order SPE2DB22D3016-SPE2DB24FAHW5
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tacrolimus 0.1% Ointment 30 gm. The contract has a ceiling value of $5,547.08 and an ultimate completion date of February 26, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,735.86 firm fixed-price contract is for the delivery of Tacrolimus 0.1% Ointment 30 GM, a specialty pharmaceutical product. The contract has an ultimate completion date of February 1, 2024 and was awarded on January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract was not set aside for any specific...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for Tacrolimus 0.1% Ointment, 30 grams. The award has a ceiling value of $6,950.91 and a completion date of January 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 100 grams of Tacrolimus 0.1% ointment, a specialty medication used for various medical conditions. The contract has a ceiling value of $6,743.56 and is a firm fixed-price delivery order with a performance period ending on January 22, 2025. The contract is not designated as a set-aside...
- This federal contract award, valued at $2,070.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 0.1% Ointment, a prescription medication, with a completion date of April 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of Tacrolimus 0.1% ointment, a specialty pharmaceutical product, with a ceiling value of $1,125.46 and a performance period through March 19, 2024. AmerisourceBergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to deliver...
- This federal contract award, valued at $3,694.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 0.1% Ointment 30GM, a medical product used in the treatment of various conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tacrolimus 0.1% Ointment 60 GM. The contract is a Firm Fixed Price (FFP) agreement with a ceiling value of $4,388.15 and a performance period through February 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,194.87 firm fixed price delivery order is for the supply of TACROLIMUS 0.03% OINTMENT 30GM, a specialty medication. The contract has an ultimate completion date of February 14, 2025 and was awarded on February 13, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,421.64 firm fixed-price delivery order is for the supply of Tacrolimus 0.1% ointment, a prescription medication, to support federal healthcare programs. The contract has an ultimate completion date of February 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAHW5Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tacrolimus 0.1% Ointment, a specialty medication, with a ceiling value of $5,418.35. The contract has an ultimate completion date of January 10, 2024 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 1/9/24 |